Literature DB >> 25446971

Statistical methods for meta-analyses including information from studies without any events-add nothing to nothing and succeed nevertheless.

O Kuss1.   

Abstract

Meta-analyses with rare events, especially those that include studies with no event in one ('single-zero') or even both ('double-zero') treatment arms, are still a statistical challenge. In the case of double-zero studies, researchers in general delete these studies or use continuity corrections to avoid them. A number of arguments against both options has been given, and statistical methods that use the information from double-zero studies without using continuity corrections have been proposed. In this paper, we collect them and compare them by simulation. This simulation study tries to mirror real-life situations as completely as possible by deriving true underlying parameters from empirical data on actually performed meta-analyses. It is shown that for each of the commonly encountered effect estimators valid statistical methods are available that use the information from double-zero studies without using continuity corrections. Interestingly, all of them are truly random effects models, and so also the current standard method for very sparse data as recommended from the Cochrane collaboration, the Yusuf-Peto odds ratio, can be improved on. For actual analysis, we recommend to use beta-binomial regression methods to arrive at summary estimates for the odds ratio, the relative risk, or the risk difference. Methods that ignore information from double-zero studies or use continuity corrections should no longer be used. We illustrate the situation with an example where the original analysis ignores 35 double-zero studies, and a superior analysis discovers a clinically relevant advantage of off-pump surgery in coronary artery bypass grafting.
Copyright © 2014 John Wiley & Sons, Ltd.

Keywords:  continuity correction; meta-analysis; rare events; safety; sparse data

Mesh:

Year:  2014        PMID: 25446971     DOI: 10.1002/sim.6383

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  44 in total

1.  Meta-Analysis of Odds Ratios: Current Good Practices.

Authors:  Bei-Hung Chang; David C Hoaglin
Journal:  Med Care       Date:  2017-04       Impact factor: 2.983

Review 2.  Software to Conduct a Meta-Analysis and Network Meta-Analysis.

Authors:  Caitlin Daly; Charlene Soobiah
Journal:  Methods Mol Biol       Date:  2022

3.  Performing Meta-analyses with Very Few Studies.

Authors:  Anke Schulz; Christoph Schürmann; Guido Skipka; Ralf Bender
Journal:  Methods Mol Biol       Date:  2022

4.  Clinical safety and efficacy of bispecific antibody in the treatment of solid tumors: A protocol for a systematic review.

Authors:  Seyed Aria Nejadghaderi; Maryam Balibegloo; Amene Saghazadeh; Nima Rezaei
Journal:  PLoS One       Date:  2022-07-18       Impact factor: 3.752

5.  Meta-analysis of primary open versus closed cannulation strategy for totally implantable venous access port implantation.

Authors:  Ulla Klaiber; Pascal Probst; Matthes Hackbusch; Katrin Jensen; Colette Dörr-Harim; Felix J Hüttner; Thilo Hackert; Markus K Diener; Markus W Büchler; Phillip Knebel
Journal:  Langenbecks Arch Surg       Date:  2021-01-09       Impact factor: 3.445

6.  Incidence of myelodysplastic syndrome and acute myeloid leukemia in patients receiving poly-ADP ribose polymerase inhibitors for the treatment of solid tumors: A meta-analysis of randomized trials.

Authors:  Roni Nitecki; Alexander Melamed; Allison A Gockley; Jessica Floyd; Kate J Krause; Robert L Coleman; Ursula A Matulonis; Sharon H Giordano; Karen H Lu; J Alejandro Rauh-Hain
Journal:  Gynecol Oncol       Date:  2021-03-15       Impact factor: 5.304

7.  Low-event-rate meta-analyses of clinical trials: implementing good practices.

Authors:  Jonathan J Shuster; Michael A Walker
Journal:  Stat Med       Date:  2016-01-05       Impact factor: 2.373

8.  Meta-analysis with zero-event studies: a comparative study with application to COVID-19 data.

Authors:  Jia-Jin Wei; En-Xuan Lin; Jian-Dong Shi; Ke Yang; Zong-Liang Hu; Xian-Tao Zeng; Tie-Jun Tong
Journal:  Mil Med Res       Date:  2021-07-03

9.  Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies.

Authors:  Christian Röver; Guido Knapp; Tim Friede
Journal:  BMC Med Res Methodol       Date:  2015-11-14       Impact factor: 4.615

10.  Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation.

Authors:  Chang Xu; Xiaoqin Zhou; Liliane Zorzela; Ke Ju; Luis Furuya-Kanamori; Lifeng Lin; Cuncun Lu; Omran A H Musa; Sunita Vohra
Journal:  BMC Med       Date:  2021-06-15       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.